Managing Immunotherapy Side Effects in Cancer Care
Early detection and grade-based care help manage immunotherapy toxicities, with tailored approaches for skin, gastrointestinal and cardiac side effects.
Early detection and grade-based care help manage immunotherapy toxicities, with tailored approaches for skin, gastrointestinal and cardiac side effects.
“It looks like our drug is a very strong candidate for treating these patients who have relapsed from current treatment options. It may potentially have the possibility to extend the survival,” said Ramesh Narayanan, the deputy director of the Center for Cancer Research and the Muirhead Endowed Professor in the College of Medicine at the… Read More
Dr. Gregory Vidal, director of clinical research at West Cancer Center and Research Institute in Memphis, chair of the breast oncology program at One Oncology and associate professor at University of Tennessee Health Science Center in Memphis, discussed the different types of treatments available for patients when they are first diagnosed with breast cancer and… Read More
Dr. Gregory Vidal, director of clinical research at West Cancer Center and Research Institute in Memphis, chair of the breast oncology program at One Oncology and associate professor at University of Tennessee Health Science Center in Memphis, explained the characteristics of this disease, among other factors, during a session of CURE® Educated Patient® Updates in… Read More